Korean J Gastroenterol.
2013 Jun;61(6):354-355. 10.4166/kjg.2013.61.6.354.
The Efficacy and Safety of a Tofacitinib in the Treatment of Active Ulcerative Colitis
- Affiliations
-
- 1Department of Internal Medicine, Digestive Disease Resecrch Institute, Wonkwang University College of Medicine, Iksan, Korea. medsgs@wonkwang.ac.kr
- KMID: 1718070
- DOI: http://doi.org/10.4166/kjg.2013.61.6.354
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
- Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in Japan
- Effects of Dextran Sulfate Sodium-Induced Ulcerative Colitis on the Disposition of Tofacitinib in Rats
- Optimal use and cycling strategies of Janus kinase inhibitors in ulcerative colitis: current evidence and clinical implications from the KASID Guidelines Task Force Team
- The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database
